Search Results 851-860 of 19766 for Receptor

  1. Chella S. David, Ph.D. - Mayo Clinic Faculty Profiles

    Role of human class I HLA-B27 transgenic mice in spondyloarthropathies. Collaborative studies on the role of MHC class I and class II genes, and T cell receptor ...

  2. Publications - Zech G. Franks, M.D. - Mayo Clinic

    ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and oral cavity. Laryngoscope Investig Otolaryngol. 2024 Feb; 9(1):e1207 ...

  3. Gene inductor do câncer não é único responsável pela doença no pâncreas, revela estudo liderado pela Mayo Clinic

    ... receptor do fator de crescimento epidérmico (EGFR – epidermal growth factor receptor). Um terceiro participante genético, conhecido como Trp53, torna os ...

  4. Michael P. Gustafson, Ph.D. - Mayo Clinic Faculty Profiles

    ... receptor T cells; and natural killer cells for early-phase clinical trials. Profiles of systemic immunity in health and disease in humans. The human immune ...

  5. Mayo breast cancer study provides critical information on tumor sequencing and response to chemotherapy

    However, Mayo investigators identified that an uncommon type of an aggressive breast cancer, the luminal androgen receptor subtype of triple negative breast ...

  6. Radiopharmaceutical therapy shows favorable results for people with tough-to-treat meningioma brain tumors, Mayo Clinic study finds

    As nearly all meningiomas express somatostatin receptors, we evaluated the efficacy of lutetium-177 (177Lu)−Dotatate for refractory meningioma. Materials ...

  7. What you should know if you take Zantac or ranitidine - Mayo Clinic News Network

    Histamine H2-receptor antagonists, also known as H2-blockers work by decreasing the amount of acid produced by the stomach. Ranitidine is an H2-blocker ...

  8. Publications - Saranya Chumsri, M.D. - Mayo Clinic

    ... Receptor-Positive, HER2-Positive Breast Cancer. J Natl ... APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor ...

  9. Alice Gallo De Moraes, M.D. - Mayo Clinic Faculty Profiles

    She has analyzed the ICU utilization of patients who received chimeric antigen receptor T-cell treatment and the most common immune-checkpoint inhibitor ...

  10. Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    Ribociclib may stop the growth of tumor cells by blocking some enzymes needed for cell growth. Cancer cells that are estrogen receptor positive may need ...